AFP-L3%, Serum

Optimal result: 0 – 9.9 %

AFP-L3% (Alpha-Fetoprotein-L3 Percent) is a specialized blood test that measures the percentage of a specific subtype of alpha-fetoprotein (AFP) in the bloodstream. AFP is a protein normally produced by the liver and yolk sac during fetal development. In adults, elevated AFP levels can be a sign of liver disease or cancer, particularly hepatocellular carcinoma (HCC), the most common type of primary liver cancer.

AFP exists in different forms, and AFP-L3 is a glycosylated variant that is more specifically associated with malignant liver tumors. The AFP-L3% refers to the proportion of total AFP that is the L3 subtype, offering more precise insight into the risk or presence of liver cancer.

AFP-L3% (Alpha-Fetoprotein-L3 Percent) is a specialized blood test that measures the percentage of a specific subtype of alpha-fetoprotein (AFP) in the bloodstream. AFP is a protein normally produced by the liver and yolk sac during fetal development. In adults, elevated AFP levels can be a sign of liver disease or cancer, particularly hepatocellular carcinoma (HCC), the most common type of primary liver cancer.

AFP exists in different forms, and AFP-L3 is a glycosylated variant that is more specifically associated with malignant liver tumors. The AFP-L3% refers to the proportion of total AFP that is the L3 subtype, offering more precise insight into the risk or presence of liver cancer.


Why is AFP-L3% tested?

This marker is most commonly used in conjunction with total AFP levels to:

  • Aid in early detection of hepatocellular carcinoma (HCC)

  • Distinguish between benign liver conditions and malignant tumors

  • Monitor high-risk patients, such as those with chronic hepatitis B or C, or cirrhosis

  • Assess cancer progression or recurrence in individuals previously diagnosed with liver cancer


How is AFP-L3% interpreted?

  • Low or undetectable AFP-L3%: Generally suggests a lower risk of liver cancer, especially when total AFP is normal.

  • Elevated AFP-L3% (typically >10%): May indicate a higher risk or presence of hepatocellular carcinoma, even if total AFP is not markedly elevated. A rising AFP-L3% over time can be an early sign of cancer development.

Important: AFP-L3% should not be used as a standalone diagnostic tool. It is most effective when interpreted alongside imaging studies (like liver ultrasound or MRI), total AFP levels, and clinical history.


Who should get tested?

AFP-L3% is typically recommended for:

  • Individuals with chronic liver disease (especially hepatitis B or C)

  • People with cirrhosis

  • Those being monitored for liver cancer recurrence after treatment

  • Individuals with elevated total AFP but inconclusive imaging results


In summary:

AFP-L3%, Serum is a highly specific biomarker used to help detect and monitor liver cancer risk, especially in people with existing liver conditions. When combined with total AFP and imaging, it provides a more accurate picture of liver health and helps guide further diagnostic or treatment decisions.

AFP-L3%, Serum
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond AFP-L3%, Serum — 10,000+ markers explained
One AFP-L3%, Serum result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro